Tag Archives: sofosbuvir

September, 2018

25 September
Gilead Subsidiary to Launch Generics of Epclusa and Harvoni for the Treatment of Hepatitis C

FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (NASDAQ: GILD) announced today plans to launch authorized generic versions of Epclusa® (sofosbuvir 400mg/velpatasvir 100mg) and Harvoni® (ledipasvir 90mg/sofosbuvir 400mg), Gilead’s leading treatments for chronic hepatitis C virus (HCV), in the United States, through a newly created subsidiary, Asegua Therapeutics LLC. The authorized generics will launch …
Share

31 March
Study Finds New Expensive Hepatitis C Drugs Are Only Cost-Effective for Certain Patients

A study, led by Boston Medical Center (BMC) researchers, assessed the cost-effectiveness of expensive new hepatitis C drugs and found that while they are highly effective, they are cost-effective and provide the greatest value in a specific groups of patients with hepatitis C. Findings from the study, led by Benjamin …
Share